Entasis Therapeutics Holdings Inc. (46) | Business Finance (22)
Browse by Subcategory
Recent Contracts
-
Amendment No. 1 to Investor Rights Agreement, dated as of May 23, 2022, by and between the Company and Parent
(Filed With SEC on May 23, 2022)
-
Registration Rights Agreement, dated February 18, 2022 by and between the Company and Innoviva
(Filed With SEC on February 18, 2022)
-
Securities Purchase Agreement, dated February 17, 2022, by and between the Company and Innoviva
(Filed With SEC on February 18, 2022)
-
Form of Warrant Certificate
(Filed With SEC on February 18, 2022)
-
Convertible Promissory Note, dated February 18, 2022
(Filed With SEC on February 18, 2022)
-
Form of Restricted Stock Unit Grant Notice (Time-Based)
(Filed With SEC on November 6, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on May 3, 2021)
-
Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva
(Filed With SEC on May 3, 2021)
-
Form of Warrant Certificate
(Filed With SEC on May 3, 2021)
-
Form of Restricted Stock Unit Grant Agreement
(Filed With SEC on November 6, 2020)
-
Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein
(Filed With SEC on September 1, 2020)
-
Securities Purchase Agreement, dated August 27, 2020, by and between the Company and the Investors named therein
(Filed With SEC on September 1, 2020)
-
Form of Pre-Funded Common Stock Purchase Warrant
(Filed With SEC on September 1, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on September 1, 2020)
-
Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva
(Filed With SEC on April 22, 2020)
-
Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva
(Filed With SEC on April 22, 2020)
-
Form of Investor Rights Agreement
(Filed With SEC on April 13, 2020)
-
Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva
(Filed With SEC on April 13, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on April 13, 2020)
-
Form of Warrant Certificate
(Filed With SEC on April 13, 2020)
-
Common Stock Purchase Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc and Aspire Capital Fund, LLC
(Filed With SEC on October 21, 2019)
-
Registration Rights Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc. and Aspire Capital Fund, LLC
(Filed With SEC on October 21, 2019)